- Fenretinide
-
- $33.00
-
2026-06-02
- CAS:65646-68-6
- Purity: 99.68%
- Supply Ability: 10g
- Fenretinide
-
- $16.00
-
2022-02-25
- CAS:65646-68-6
- Min. Order: 1Kg/Bag
- Purity: 99%
- Supply Ability: 3kg
|
| | 4-HYDROXYPHENYLRETINAMIDE Basic information |
| Product Name: | 4-HYDROXYPHENYLRETINAMIDE | | Synonyms: | 4-HYDROXYPHENYLRETINAMIDE;4HPR;p-Hydroxyphenylretinamide;4-HPR, Fenretinide, N-(4-Hydroxyphenyl)retinamide;(2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenamide;Fenretinimide;Fenretinide(4-HPR);RetinaMide,N-(4-hydroxyphenyl)- | | CAS: | 65646-68-6 | | MF: | C26H33NO2 | | MW: | 391.55 | | EINECS: | 200-256-5 | | Product Categories: | Intracellular receptor;Intermediates & Fine Chemicals;Pharmaceuticals;Retinoids;Drug Analogues;Inhibitors | | Mol File: | 65646-68-6.mol |  |
| | 4-HYDROXYPHENYLRETINAMIDE Chemical Properties |
| Melting point | 162-163°C | | Boiling point | 597.6±42.0 °C(Predicted) | | density | 1.081±0.06 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Orange solid | | pka | 9.98±0.26(Predicted) | | color | Yellow | | biological source | synthetic (organic) | | λmax | 362nm(MeOH)(lit.) | | Merck | 14,3998 | | Stability: | Light Sensitive - Protect from Light Exposure | | InChIKey | AKJHMTWEGVYYSE-FXILSDISSA-N | | SMILES | C(NC1=CC=C(O)C=C1)(=O)/C=C(/C=C/C=C(/C=C/C1C(C)(C)CCCC=1C)\C)\C | | CAS DataBase Reference | 65646-68-6(CAS DataBase Reference) |
| Hazard Codes | T | | Risk Statements | 60-61-20/21/22-36/37/38 | | Safety Statements | 53-26-36/37/39-45-52 | | WGK Germany | 3 | | RTECS | VH6420000 | | HS Code | 2924297099 | | Storage Class | 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 4 Dermal
Acute Tox. 4 Inhalation
Acute Tox. 4 Oral
Eye Irrit. 2
Repr. 1B
Skin Irrit. 2
STOT SE 3 |
| | 4-HYDROXYPHENYLRETINAMIDE Usage And Synthesis |
| Chemical Properties | 4-HYDROXYPHENYLRETINAMIDE is Yellow Powder | | Uses | 4-HYDROXYPHENYLRETINAMIDE is an effective agent for the chemoprevention and growth modulation of oncogene-induced prostate cancer in the mouse prostate reconstitution model system and may be effective for the chemoprevention of human prostate cancer | | Uses | A synthetic analog of Vitamin A. | | Uses | Retinoic acid receptor ligand | | Definition | ChEBI: A retinoid obtained by formal condensation of the carboxy group of all-trans retinoic acid and the anilino group of 4-hydroxyaniline. Synthetic retinoid agonist. Antiproliferative, antioxidant and anticancer agent with a long half-life in
ivo. Apoptotic effects appear to be mediated by a mechanism distinct from that of 'classical' retinoids. | | General Description | Retinoic acid p-hydroxyanilide is a synthetic analog of retinoid. | | Biological Activity | Synthetic retinoid agonist. Antiproliferative, antioxidant and anticancer agent with a long half-life in vivo . Apoptotic effects appear to be mediated by a mechanism distinct from that of 'classical' retinoids. | | Biochem/physiol Actions | Vitamin A acid analogue with antiproliferative activity; induces apoptosis in malignant hemopoietic cell lines. | | storage | Store at -20°C | | references | [1] roberto benelli, stefano monteghirfo, roberta venè, francesca tosettiand nicoletta ferrari.the chemopreventive retinoid 4hpr impairs prostate cancer cell migration and invasion by interfering with fak/akt/gsk3β pathway andβ-catenin stability. molecular cancer.2010, 9:142-154.
[2] anita l. sabichi, denver t. hendricks, mary a. bober, michael j. birrer. retinoic acid receptorβexpression and growthinhibition of gynecologic cancer cells by thesynthetic retinoidn-(4-hydroxyphenyl) retinamide. journal of the national cancer institute. 1998, 90(8): 597-605.
[3] shi-yong sun, ping yue, and reuben lotan. induction of apoptosis by n-(4-hydroxyphenyl)retinamide andits association with reactive oxygen species, nuclearretinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells.molecular pharmacology. 1999, 55:403–410. |
| | 4-HYDROXYPHENYLRETINAMIDE Preparation Products And Raw materials |
|